BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 31407723)

  • 41. Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.
    Østergaard JA; Laugesen E; Leslie RD
    Curr Diab Rep; 2016 Sep; 16(9):82. PubMed ID: 27457237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Latent Autoimmune Diabetes in Adults: What is Best?
    Hals IK
    Curr Diabetes Rev; 2019; 15(3):188-193. PubMed ID: 30009709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Past, present and future of latent autoimmune diabetes in adults.
    Liu B; Xiang Y; Liu Z; Zhou Z
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3205. PubMed ID: 31318117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune diagnostics in diabetes mellitus.
    Seissler J; Scherbaum WA
    Clin Chem Lab Med; 2006; 44(2):133-7. PubMed ID: 16475896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy.
    Yin W; Luo S; Xiao Z; Zhang Z; Liu B; Zhou Z
    Front Endocrinol (Lausanne); 2022; 13():959011. PubMed ID: 35992113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based report.
    Lutgens MW; Meijer M; Peeters B; Poulsen ML; Rutten MJ; Bots ML; van der Heijden GJ; Soedamah-Muthu SS
    Prim Care Diabetes; 2008 Dec; 2(4):207-11. PubMed ID: 18815086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Innate immunity in latent autoimmune diabetes in adults.
    Huang J; Pearson JA; Wong FS; Wen L; Zhou Z
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3480. PubMed ID: 34156143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Review on Latent Autoimmune Diabetes in Adults.
    Ravikumar V; Ahmed A; Anjankar A
    Cureus; 2023 Oct; 15(10):e47915. PubMed ID: 38034250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.
    Hu J; Zhang R; Zou H; Xie L; Zhou Z; Xiao Y
    Front Endocrinol (Lausanne); 2022; 13():917169. PubMed ID: 35937817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Latent Autoimmune Diabetes in Adults and Metabolic Syndrome-A Mini Review.
    Pan N; Yang S; Niu X
    Front Endocrinol (Lausanne); 2022; 13():913373. PubMed ID: 35837301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type of diabetes mellitus: Does it matter to the clinician?
    Hoogwerf BJ
    Cleve Clin J Med; 2020 Feb; 87(2):100-108. PubMed ID: 32015063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Latent autoimmune diabetes in adults (LADA) in Asian and European populations.
    Kumar A; de Leiva A
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28198081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Latent (slowly progressing) autoimmune diabetes in adults.
    Seissler J
    Curr Diab Rep; 2008 Apr; 8(2):94-100. PubMed ID: 18445350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Latent autoimmune diabetes in adults].
    Hummel M
    MMW Fortschr Med; 2020 Jun; 162(11):60-63. PubMed ID: 32514953
    [No Abstract]   [Full Text] [Related]  

  • 56. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.
    Pipi E; Marketou M; Tsirogianni A
    World J Diabetes; 2014 Aug; 5(4):505-10. PubMed ID: 25126396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.
    Liao Y; Xiang Y; Zhou Z
    Front Med; 2012 Sep; 6(3):243-7. PubMed ID: 22843304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical Diabetes and Management Considerations.
    Patil SP
    Prim Care; 2022 Jun; 49(2):225-237. PubMed ID: 35595479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy.
    Siddiqui K; Nawaz SS
    Immunotargets Ther; 2023; 12():91-103. PubMed ID: 37795196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives.
    Nishimura A; Matsumura K; Kikuno S; Nagasawa K; Okubo M; Mori Y; Kobayashi T
    Diabetes Metab Syndr Obes; 2019; 12():2461-2477. PubMed ID: 31819572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.